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Medical history of discordant twins and environmental
etiologies of autism
C Willfors1,2,9, T Carlsson1,3,9, B-M Anderlid4,5, A Nordgren4,5, E Kostrzewa1,2, S Berggren1,2,6, A Ronald7, R Kuja-Halkola8,
K Tammimies1,2 and S Bölte1,2,6
The environmental contributions to autism spectrum disorder (ASD) and their informative content for diagnosing the condition are
still largely unknown. The objective of this study was to investigate associations between early medical events and ASD, as well as
autistic traits, in twins, to test the hypothesis of a cumulative environmental effect on ASD risk. A total of 80 monozygotic (MZ) twin
pairs (including a rare sample of 13 twin pairs discordant for clinical ASD) and 46 dizygotic (DZ) twin pairs with varying autistic traits,
were examined for intra-pair differences in early medical events (for example, obstetric and neonatal factors, ﬁrst year infections).
First, differences in early medical events were investigated using multisource medical records in pairs qualitatively discordant for
ASD. The signiﬁcant intra-pair differences identiﬁed were then tested in relation to autistic traits in the remaining sample of 100
pairs, applying generalized estimating equations analyses. Signiﬁcant association of the intra-pair differences in the MZ pairs were
found for the cumulative load of early medical events and clinical ASD (Z=− 2.85, P= 0.004) and autistic traits (β= 78.18, P= 0.002),
as well as infant dysregulation (feeding, sleeping abnormalities, excessive crying and worriedness), when controlling for intelligence
quotient and attention deﬁcit hyperactivity disorder comorbidity. The cumulative load of early medical events in general, and infant
dysregulation in particular, may index children at risk of ASD owing to non-shared environmental contributions. In clinical practice,
these ﬁndings may facilitate screening and early detection of ASD.
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INTRODUCTION
Autism spectrum disorder (ASD) is an increasingly diagnosed
neurodevelopmental condition with a heterogeneous and life-
long presentation. It is exclusively behaviorally deﬁned by an early
onset of persistent difﬁculties in social communication and
interaction, alongside repetitive, restricted interests and activities
causing impairment in daily life.1 Traits of autism are continuously
distributed in the general population and overlap with clinical
phenotypes of ASD.2–4 Comorbidity with other neurodevelop-
mental disorders is common in ASD.5 Symptoms of ASD are
typically measurable at the age of 12 months, still most cases are
diagnosed much later.6 Early behavioral signs of ASD are limited in
sensitivity and speciﬁcity, and current screening tools show low
positive predictive values.7 Establishing reliable early detection of
the condition remains a clinical research priority, as early
identiﬁcation typically ensures access to intervention and
facilitates improved outcomes.8
Twin and family studies have shown both genetic and
environmental factors to be inﬂuential in ASD etiology with
heritability estimates ranging from 38 to 55%9,10 up to 95%,3 and
non-shared environmental (NSE) factors to be the predominant
environmental inﬂuence.9,11 For autistic traits, a British population-
based twin study reported evidence that twins with more
neonatal problems had more autistic traits. For example, lower
birth weight was associated with more autistic traits in the social
domain in middle childhood.12 Multiple single environmental risks
have been implicated in ASD, both shared environment (SE)
factors, such as maternal valproate intake, exposure to toxic
chemicals, enhanced steroidogenic activity, gestational diabetes
and maternal obesity, and NSE factors, such as birth injury and
trauma, and neonatal anemia.13–16 Bolton et al.17 in their study on
the relevance of obstetric complications on ASD etiology, found
that rather than playing any primary causal role, the birth
complications associated with autism either represent an epiphe-
nomenon of the condition or derive from shared risk factor(s). A
number of environmental risk factors have been suggested to lead
to epigenetic dysregulation, and increase ASD risk, such as
prenatal exposure to valproate.18 Overall, the current evidence
favors a multiple risk factor threshold model hypothesizing that an
increased exposure to a composition of environmental stressors
increases the risk for ASD in individuals with a genetic
vulnerability.19 Further, it is suggested that the cumulative load
of risk factors correlates with the severity of ASD.19
As genetic factors inﬂuence how individuals respond to
different environmental exposures, limited control over the
individual genetic factors has been a major weakness of most
studies investigating environmental risks for ASD. As monozygotic
(MZ) twins are identical on a DNA sequence level, with the
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exception of putative post-twinning de novo mutations, all
differences in phenotypes seen in MZ twin pairs are attributable
to effects of NSE.20 Particularly studies investigating MZ pairs
discordant for the phenotype in question are powerful to
elucidate environmental risk factors.21 Only a few studies have
applied a discordant MZ twin pair design in ASD as reviewed by
Ronald and Hoekstra.11
The objective of this study was to explore associations between
potential environmental risk factors, ASD and autistic traits.
Speciﬁcally, we sought to identify early medical events likely to
be caused by environmental factors that are associated with ASD
and autistic traits, and test the hypothesis of their cumulative
effect on risk status. For this purpose, we scrutinized the early
medical histories of a rare and informative sample of 13 MZ twin
pairs discordant for clinical ASD. The ﬁndings were then cross-
validated in a separate larger cohort of MZ and dizygotic (DZ)
twins discordant for autistic traits (N= 100 pairs), operationalizing
them in a cumulative multifactorial model. The results of this study
provide information about early medical events and adverse
behavioral manifestations that may index children at risk for ASD,
owing to NSE inﬂuences. Such evidence could be used to facilitate
early detection of ASD, as it might either further support or
discourage an existing diagnostic suspicion.
MATERIALS AND METHODS
Diagnostic and behavioral assessments
The participants were diagnosed by three experienced clinicians according
to DSM-5 criteria using clinical consensus supported by results from the
Autism Diagnostic Interview – Revised,22 the Autism Diagnostic Observa-
tion Schedule Second Edition,23 the Kiddie Schedule for Affective Disorders
and Schizophrenia24 or the Diagnostic Interview for attention deﬁcit
hyperactivity disorder (ADHD) in Adults.25 The Wechsler Intelligence Scales
for Children or Adults, Fourth Editions,26,27 or the Leiter-revised scales28 in
combination with the Peabody Picture Vocabulary Test Third Edition29 (in
cases of low verbal abilities) and the parent-rated Adaptive Behavior
Assessment Scale, 2nd Edition,30 were applied to assess general cognitive
and verbal abilities and adaptive functional level. Autistic traits were
measured by the parent report version of the Social Responsiveness Scale-
2 (SRS-2) using total raw scores as recommended for research settings.31
The SRS-2 includes 65 Likert scaled items, generating a total maximum
score of 195. The questions in SRS-2 focus on the individual’s behavior
during the past 6 months and inquiries about autistic traits, such as
alterations in social cognition, social awareness, social motivation, social
communication and inﬂexible, repetitive behavior. Increasing scores on
the SRS-2 indicate more autistic traits. The SRS-2 has demonstrated
satisfactory-to-excellent psychometric properties for test–retest reliability
(0.80–0.97), interrater reliability (0.75–0.95) and convergent validity
(0.35–0.58).32,33
The exposure of early medical events were assessed in relation to either
quantitative or qualitative discordance for ASD. Qualitative discordance
was deﬁned as only one twin within a pair meeting the diagnostic criteria
of ASD, and quantitative discordance as at least one point intra-pair
difference on the SRS-2 total score. In the ﬁrst step of analyses, intra-pair
medical event differences in a sample of qualitative ASD discordant twins
was examined and compared with TD controls. In the second step of
analyses, the association between identiﬁed medical events (exposure)
and quantitative discordance for ASD (outcome) was assessed.
Participants
The study was approved by the National Swedish Ethical Review Board and
all the participants and/or their legal guardians gave written informed
consent. A total of 126 twin pairs (80 MZ, 46 DZ) were recruited from the
‘Roots of Autism and ADHD Twin Study in Sweden’ described elsewhere in
detail.34
ASD discordant MZ twin sample. The ﬁrst analysis step (exploratory)
included 13 MZ twin pairs discordant for clinical ASD and 13 MZ typically
developing (TD) control pairs (n= 52) matched for sex (16 males and 10
females in each group). Among the twins with ASD, ﬁve had a comorbid
diagnoses of ADHD. The total intelligence quotient (IQ) in the ASD
discordant twin sample ranged from 40 to 121 (M=89.2), and 81 to 123
(M= 98.1) in the TD control twins. A quantitative intra-pair difference was
found for all but two of the behavioral measures, with the largest effect
size for the SRS-2 total score (r=0.85, Z=− 3.06, P=0.002), that was higher
in the ASD twin, and the second largest for full-scale IQ (r= 0.80, Z=− 2.87,
P= 0.004), that was higher in the non-ASD twin. Effect sizes were calculated
according to r= Z/√N. These intra-pair differences were not found in the
13 TD MZ pairs (Supplementary Tables 1 and 2).
Autistic trait discordant MZ and DZ twin sample. In the second step of
analysis (conﬁrmatory), we included 100 twin pairs quantitatively
discordant for autistic traits, 54 MZ pairs and 46 DZ pairs. In the MZ
group, 29 participants were assessed positive for ASD, 32 positive for
ADHD and 13 were positive for both disorders. The equivalent numbers in
the DZ groups were 23 participants with ASD, 35 with ADHD and 13 with
ASD and ADHD combined. IQ ranged from 42 to 142 in the total sample,
with a mean of 96.6 in the MZ group and a mean of 97.7 in the DZ group.
The percentage of females was 44% in the MZ group and 46% in the DZ
group (Table 1).
Zygosity
Zygosity was determined by genotyping of saliva or whole-blood derived
DNA using Inﬁnium Human-CoreExome chip (Illumina, San Diego, CA,
USA). The estimating identity by descent was analyzed using the PLINK
software35 after quality control and removal of SNPs with minor allele
frequency less than 0.05 within the samples. All pairs of DNA samples
Table 1. Sample characteristics
Samples N pairs Age mean (range) Sex: n subjects ASD cases: n subjects IQ full-scale mean (range)
MZ discordant for ASD diagnoses 13 14.4 y (9–20) Male: 16
Female: 10
ASD cases: 13
ADHD cases: 6
Cases with comorbid ASD and ADHD: 5
89.2 (40–121)
MZ TD 13 15.8 y (10–18) Male: 16
Female: 10
ASD cases: —
ADHD cases: —
98.1 (81–123)
MZ quantitative discordant 54 14.9 y (8–28) Male: 60
Female: 48
ASD cases: 29
ADHD cases: 32
Cases with comorbid ASD and ADHD: 13
96.6 (58–142)
DZ quantitative discordant 46 14.3 y (8–25) Male: 49
Female: 43
ASD cases: 23
ADHD cases: 35
Cases with comorbid ASD and ADHD: 13
97.7 (42–138)
Abbreviations: ADHD, attention deﬁcit hyperactivity disorder; ASD, autism spectrum disorder; DZ, dizygotic; IQ, intelligence quotient; MZ, monozygotic; TD,
typically developed; y, year.
Environmental contribution to ASD in discordant twins
C Willfors et al
2
Translational Psychiatry (2017), 1 – 6
showing π^ ⩾ 0.99 were considered as monozygotic pairs. For few pairs, a
short tandem repeat kit (Promega Powerplex 21) or zygosity questionnaire
(six pairs) was used.
Medical and developmental history
For the exploratory ﬁrst step of analyses comparing qualitative ASD
discordant MZ twins to TD MZ twin controls, detailed information on
medical and developmental history with focus on the ﬁrst 5 years of life
was collected from questionnaires and medical records. Intraclass
Correlation Coefﬁcient (ICC) analysis36 showed good agreement between
the questionnaire and medical record information. The agreement was
moderate for cumulative load of early medical events (ICC= 0.55, 95%
conﬁdence interval = 0.22–0.75), substantial for dysregulation (ICC = 0.76,
95% conﬁdence interval = 0.58–0.86) and almost perfect for birth weight
(ICC= 0.93, 95% conﬁdence interval = 0.88–0.96). Medical records com-
prised prenatal records, birth records, records of pediatric clinics and
medical and psychiatric care unit documentation. Medical history in the
total sample was assessed from a parent reported questionnaire. The 114
items of the questionnaire covered medical history events such as current
diagnosis and medications, family situation at birth, family medical history,
pre-, peri- and postnatal factors, child disease history and diagnostic tests.
Most questions were yes/no questions with a request to specify for positive
answers. In some cases, the questions on paper were followed up with an
interview with clinical geneticists for clariﬁcations. The questionnaire data
and health care records for the subsample were reviewed independently
by four researchers (TC, B-MA, AN, CW) with different clinical backgrounds
(that is, child and adolescent psychiatrist, neuropediatrician, clinical
geneticist and psychologist). Two of the researchers (B-MA, AN) were
blinded for clinical diagnoses, hypotheses and planned analysis. Intra-pair
differences for the frequency and age of onset for developmental
alterations, medical complications and life events were noted. In the case
of contradictory information, a decision-making hierarchy was applied on
the basis of the presumed validity of the information sources. For example,
birth weight data from the birth record was considered more valid than
the same information from the questionnaire. Registered medical history
events were coded binary (‘1’ for present, ‘0’ for not present in each
individual; Supplementary Table 3). In addition, the medical history events
were categorized according to the type of events (for example, delivery-
related factors and minor and frequent infections) and summarized into
ordinal data. All medical history events, that by the four researchers, were
identiﬁed as differing within ASD discordant pairs (that is, present in only
one twin in a pair), were added up to generate a cumulative load of early
medical events for each individual (31 factors). To deal with missing data
(NA), the sum of individual factors was divided with the total number of
variables, subtracted with the individual number of missing variables
according to the formula below.
Cumulative load ¼ Σ medical history events
31 -NA
The mean number of missing data in the sample was 1.7 (range 0–23). In
addition to the binary code of intra-pair birth weight differences, the
quantitative information (differences in grams) was used in a separate
analysis of birth weight.
Statistical analysis
Statistics were computed using IBM SPSS 22 and the drgee package37 in
R version 3.2.4. Owing to the sample size, nonparametric tests were used
(that is, Wilcoxon signed-rank test for continuous and ordinal data and
McNemar’s test for binary data) to assess the within-pair effect for the
identiﬁed medical events in the qualitative discordant MZ subsample. All
the tests in the ﬁrst step of analyses were two-tailed. In the second step of
analyses of the quantitative discordant sample, a conditional linear
regression model, based on generalized estimating equations analysis38
was ﬁtted. The conditional model estimates the within-pair effect,
adjusting for all shared factors in twin pairs (for example, all genetic
factors in MZ pairs).39 One-tailed tests were applied for the regression
analyses. Autistic trait severity (SRS-2 total score) was used as outcome
variable in the model. The model was adjusted for the following covariates:
full-scale IQ, ADHD diagnoses (binary) and sex. In addition, the sample was
split into zygosity groups comparing the within-pair effects in the MZ and
DZ pairs.
RESULTS
Early medical history in twins discordant for clinical ASD
Single early medical factors, likely to be caused by NSE, that
discriminated between twins in qualitative ASD discordant pairs
were dysregulation during the ﬁrst year of life (comprising feeding
and sleeping problems, excessive crying and worrying; Z=− 2.56,
P= 0.011) and birth weight (Z=− 2.20, P= 0.028) (Table 2). MZ
twins with ASD and their non-ASD co-twins also differed for the
cumulative load of early medical events (Z=− 2.85, P= 0.004;
Table 2, Figure 1). None of these intra-pair differences were
observed in the 13 TD MZ pairs (Figure 1).
Early medical history in autistic traits discordant twins
A single early medical factor, likely to be caused by NSE, that
correlated with the extent of autistic traits was dysregulation during
the ﬁrst year of life (β=31.75, P=0.03). The association for birth
weight and ASD traits was not signiﬁcant, but showed a similar
trend (β=− 0.01, P=0.05; See Table 3). There was an association
between the intra-pair differences in cumulative load of early
medical events and autistic traits in the MZ pairs (β=78.18,
P=0.002; Table 3). This effect indicates a three point intra-pair
increase for autistic traits on the SRS-2 for every single medical
event’s difference. All models were adjusted for full-scale IQ and
ADHD diagnoses, with no signiﬁcant gender effect found. The
association between autistic traits and the cumulative load of early
medical events hold also when excluding the dysregulation variable
from the cumulative load score (β=54.42, P=0.005). No signiﬁcant
associations were seen in the DZ pairs (Table 3; Figure 2).
DISCUSSION
In this study, we show that early medical events are associated with
clinical ASD phenotypes and continuously distributed autistic traits.
The latter was particularly true for early dysregulation and the
cumulative load of a variety of early adverse medical events. Using
co-twin modeling, we were able to control for genetic and SE
factors, endorsing that the found associations were indeed driven
by NSE factors within the MZ twin pairs. Our study show the novel
ﬁnding of a cumulative environmental effect on ASD risk, when
controlling for genetics. In addition, we were able to replicate earlier
ﬁndings of early dysregulation as a precursor of behavioral
problems and autistic traits. A previous large population-based
study including over 4000 infants reported that early regulatory
problems predict behavioral problems (that is, external, internal and
attentional problems) later in life,40 and a Swedish clinical study
found that regulatory issues were frequent in children later
diagnosed with ASD.41 Our results advance these results because
they demonstrate that an association between early regulation
difﬁculties and ASD exists independent of genetic inﬂuences. Earlier
studies were unable to differentiate genetic and environmental
effects on these phenomena. In line with a previous community
twin study,12 we found that an increased total load of early medical
events is associated with autistic traits. Nevertheless, the associa-
tions identiﬁed in the current studies were substantially stronger.
Our study partly supports previous results indicating low birth
weight to be associated with ASD risk.20 We found a trend for
intrauterine growth to be associated with clinical ASD and autistic
traits. However, although earlier studies deemed low birth weight
a consequence of genetic factors, our data indicate environmental
factors as cause. In addition to highlighting NSE factors causing
early developmental adversity in ASD, our results also suggest
early adversity factors being of potential relevance as early red
ﬂags for autism risk evaluation. Although symptoms of ASD
emerge as early as 12 months of age,6 and ASD can quite reliably
be diagnosed between 24 and 36 months of age, many children
are not diagnosed until the age of 5 or 6 years. This is unfortunate
as early detection is a prerequisite for early intervention,42 which is
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associated with better outcomes.43 The screening tools available
for ASD before the age of 24 months are limited in sensitivity and
speciﬁcity,43 and as the condition is exclusively behaviorally
deﬁned, the tools do not include early medical features. Our data
indicate that taking into account the cumulative load of early
medical factors might strengthen or discourage a suspicion of
ASD, at least in a minority of cases. However, further research
should explore how these general risk factors could be practically
useful for identifying a speciﬁc condition such as ASD.
Our study harbors some noteworthy strengths. For instance,
although there is a large phenotypic as well as etiological overlap
between ASD, intellectual disability and ADHD,44 few ASD studies
have taken comorbid diagnoses into consideration, either exclud-
ing comorbidity, not assessing it at all or limiting the ASD sample
to those individuals without intellectual disabilities. This study
controlled for the effects of IQ as well as diagnosis of ADHD,
indicating that results are speciﬁc to ASD. Interestingly, ﬁndings
were not limited to clinical ASD phenotypes, but equally valid for
autistic traits, providing further support for the notion that ASD
forms the extreme end of a trait continuum.2–4 The importance of
investigating mental health from a quantitative perspective is
endorsed by the American National Institutes of Health Research
Domain Criteria approach, attempting to classify mental disorders
incorporating multiple dimensional outcomes rather than single
categorical diagnoses. A growing body of literature supports that
several currently exclusively behavioral deﬁned psychiatric diag-
noses could be enriched and clariﬁed by multidimensional
information, and a medical and environmental factor association
speciﬁer has been added to the ASD diagnostic criteria in the ﬁfth
edition of DSM.45,46 In this regard, our ﬁndings endorse that
information on the cumulative load of early medical events might
qualify to be speciﬁed in the context of ASD assessment.
This study has several limitations that need to be addressed. First,
the cumulative load of early medical events, as well as dysregula-
tion, might not be primary or directly acting environmental risk
factors for ASD, such as maternal valproate intake. These factors
might be secondary (or tertiary), although they precede an ASD
diagnosis, as we in this study are unable to draw ﬁrm conclusions
about the possible primary factors. Second, we cannot ﬁnally
exclude that possible selection and conﬁrmation bias, and reverse
causation limit the generalizability of our conclusions. However, as
we use medical records as a source of information, we assume to
have collected reliable data of a child’s medical history, hence
eliminating recall bias. Two of the abstractors of the medical records
were unblinded to the diagnosis of the twins. Although, there were
no systematic differences between the data abstracted by the
blinded vs the non-blinded clinicians, and such a bias is unlikely for
Table 2. List of the non-shared variables and categories included in
the cumulative load of early medical events and intra-pair differences
in MZ pairs qualitative discordant for ASD (n= 13 pairs)
Categories Wilcoxon
sign-rank
test
Variables McNemar’s/
Wilcoxon
sign-rank test
Delivery related
factors
Z=− 1.34
P= 0.180
Apgar 5 min —
Fetal distress —
Breech birth P= 0.625
Minor medical
neonatal factors
Z=− 1.51
P= 0.131
Hypoglycemia —
Hyperbilirubinemia P= 1.00
Oxygen treatment —
Iron depletion —
Thrombocytopenia —
Growth at birth — Birth weight Z=− 2.20
P= 0.028*
Microcephaly — Head circumference
relative to length
P= 0.219
Minor and
frequent
infections
Z=− 0.58
P= 0.564
Frequent ear
infections
P= 1.00
Infections asthma
before 5 y
P= 1.00
Gastroenteritis o2 y —
Serious
infections o2 y
Z= 0.00
P= 1.00
Pyelonephritis o2 y —
Septicemia o2 y P= 1.00
Total allergy — Eczema o5 y P= 1.00
Allergy o5 y —
Total epilepsy
o5 y
Z=− 1.41
P= 0.157
Epilepsy o5 y —
Seizures ﬁrst year P= 0.50
Serious medical
conditions ﬁrst
year
Z=− 1.00
P= 0.317
Cerebral hemorrhage P= 1.00
Cerebral paresis —
Hydrocephalus —
Congenital heart
and vessel
malformations
— Heart and large
vessels malformation,
Cerebral AVM
—
Brain atrophy — Brain atrophy —
Head contusion — Head contusion
o3 y
—
Visual
impairments
— Glasses P= 1.00
Dysregulation
o1 y
Z=− 2.56
P= 0.011*
Poor sleep P= 0.063
Feeding disabilities P= 0.125
Frequent vomiting —
Crying a lot P= 0.250
Worried o1 y —
The cumulative
load of early
medical events
Z=− 2.85
P= 0.004**
Including all above-
listed variables
Abbreviations: ASD, autism spectrum disorder; AVM, arteriovenous
malformation; MZ, monozygotic; y, year. *Po0.05, **Po0.01.
Figure 1. The adjusted cumulative load of medical events in ASD
discordant and typically developed MZ twins. ASD, autism spectrum
disorder; MZ, monozygotic.
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the autistic traits analyses, some degree of conﬁrmation bias cannot
be ruled out. Third, although we stress here the signiﬁcance of NSE,
as we apply a high genetic control, rare post-twining de novo
mutations are acknowledged and may contribute to a minority of
cases of discordance. Fourth, this study is unable to weight the
different factors summing up to the cumulative load, making our
approach crude. Fifth, one might consider the sample size of the
ASD discordant pairs included in the ﬁrst step of the study to be
small. However, MZ twin designs offer a high degree of control for
confounders, and our ASD discordant sample actually represents a
rather large minority of those discordant pairs in Sweden.47 Sixth,
despite the advantages of twin studies, twins might not always be
representative of the general population, making cross-validation of
twin ﬁndings in singletons desirable for conﬁrm generalizability. For
example, a factor such as shared or non-shared placenta, could
have a MZ twin-speciﬁc NSE effect that we have not been able to
control for in this study. Nevertheless, twinness in itself has not
been shown to be a risk factor for ASD,48 nor autistic traits.49
In summary, we found (i) that the load of adverse early medical
events is associated with autistic traits and ASD; (ii) a link between
autistic traits, ASD and early dysregulation; (iii) that these early
medical events are likely to be driven by NSE; and (iv) that the
cumulative load of early medical events could be informative in
the early detection of ASD. Our ﬁndings require an independent
follow-up in epidemiological samples, for conﬁrmation of the
results and to investigate the speciﬁcity with regard to other
neurodevelopmental disorders.
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